Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.93
+0.02 (0.29%)
At close: Dec 16, 2025, 4:00 PM EST
6.93
0.00 (0.00%)
Pre-market: Dec 17, 2025, 4:40 AM EST
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $1.93B in the quarter ending September 30, 2025, with 3.77% growth. This brings the company's revenue in the last twelve months to $9.27B, up 5.15% year-over-year. In the year 2024, Bausch Health Companies had annual revenue of $7.78B, down -11.13%.
Revenue (ttm)
$9.27B
Revenue Growth
+5.15%
P/S Ratio
0.26
Revenue / Employee
$484,493
Employees
20,700
Market Cap
2.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.78B | -974.53M | -11.13% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
| Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
| Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
| Dec 31, 2016 | 9.67B | -773.00M | -7.40% |
| Dec 31, 2015 | 10.45B | 2.24B | 27.31% |
| Dec 31, 2014 | 8.21B | 2.44B | 42.23% |
| Dec 31, 2013 | 5.77B | 2.29B | 65.77% |
| Dec 31, 2012 | 3.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BHC News
- 8 days ago - Bausch Health Announces Early Exchange Offer Results for Exchange Offers - Accesswire
- 14 days ago - Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 16 days ago - Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China - Accesswire
- 23 days ago - Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes - Accesswire
- 4 weeks ago - Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference - Accesswire
- 4 weeks ago - Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day - Business Wire
- 5 weeks ago - Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path - Seeking Alpha
- 5 weeks ago - Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease - Accesswire